Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 032049/0357 | |
| Pages: | 4 |
| | Recorded: | 01/27/2014 | | |
| Attorney Dkt #: | MEDAREX LLC/AMGEN |
| Conveyance: | MERGER (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
6
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/17/2015
|
Application #:
|
12976802
|
Filing Dt:
|
12/22/2010
|
|
Publication #:
|
|
Pub Dt:
|
05/05/2011
| | | | |
|
Title:
|
Human anti-B7RP1 Neutralizing Antibodies
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/04/2013
|
Application #:
|
13360454
|
Filing Dt:
|
01/27/2012
|
|
Publication #:
|
|
Pub Dt:
|
06/21/2012
| | | | |
|
Title:
|
Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/27/2013
|
Application #:
|
13450126
|
Filing Dt:
|
04/18/2012
|
|
Publication #:
|
|
Pub Dt:
|
10/25/2012
| | | | |
|
Title:
|
THERAPEUTIC HUMAN ANTI-IL-1R1 MONOCLONAL ANTIBODY
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
13794690
|
Filing Dt:
|
03/11/2013
|
|
Publication #:
|
|
Pub Dt:
|
07/04/2013
| | | | |
|
Title:
|
Human Anti-OPGL Neutralizing Antibodies as Selective OPGL Pathway Inhibitors
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/29/2014
|
Application #:
|
13961537
|
Filing Dt:
|
08/07/2013
|
|
Publication #:
|
|
Pub Dt:
|
02/06/2014
| | | | |
|
Title:
|
THERAPEUTIC HUMAN ANTI-IL-1R1 MONOCLONAL ANTIBODY
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/09/2014
|
Application #:
|
13966185
|
Filing Dt:
|
08/13/2013
|
|
Publication #:
|
|
Pub Dt:
|
01/02/2014
| | | | |
|
Title:
|
Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors
|
|
|
Assignee
|
|
|
|
|
| ROUTE 206 AND PROVINCE LINE ROAD |
| PRINCETON, NEW JERSEY 08540 |
|
|
Correspondence name and address
|
| |
BRISTOL-MYERS SQUIBB COMPANY
|
| |
ROUTE 206 AND PROVINCE LINE ROAD
|
| |
PRINCETON, NJ 08540
|
Search Results as of:
05/13/2024 08:47 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
